Loading…
Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins
To be both safe and effective, a therapeutic product must have the correct chemical structure and be free of harmful contaminants. Structure in protein therapeutic products, however, implies not only the correct sequence of amino acids (primary structure) but also the proper folding of that amino ac...
Saved in:
Published in: | Biologicals 2002-09, Vol.30 (3), p.175-185 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3 |
container_end_page | 185 |
container_issue | 3 |
container_start_page | 175 |
container_title | Biologicals |
container_volume | 30 |
creator | Cauchy, Mike D'aoust, Sophie Dawson, Brian Rode, Harold Hefford, Mary Alice |
description | To be both safe and effective, a therapeutic product must have the correct chemical structure and be free of harmful contaminants. Structure in protein therapeutic products, however, implies not only the correct sequence of amino acids (primary structure) but also the proper folding of that amino acid chain in three-dimensional space (tertiary structure). This work is part of a general strategy to develop a battery of physico-chemical methods that could give assurances of structure (and hence function) in formulated therapeutic proteins in the absence of
in vivo data. It focuses on recombinant human growth hormone (rhGH), a well-characterized therapeutic protein, and examines the utility of thermodynamic parameters in assessing its tertiary structure. Resistance of solutions of formulated rhGH to thermal denaturation was followed using Fourier Transform Infrared Spectroscopy (FTIR) by observing decreases in total helicity and increases in intermolecular beta-sheet formation. Under conditions known to induce changes in the intra-molecular ionic and H-bonding patterns stabilizing the tertiary structure but not affecting the protein's secondary structure or global fold, we have observed upwards of a 12°C shift in the melting temperature of the protein. Furthermore, our results indicated that the
T
m of unfolding of rhGH was sensitive to much more subtle changes in the protein structure. Thus, resistance to thermal denaturation may well be a useful means to measure structure in formulations of well-characterized therapeutic proteins.
Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved. |
doi_str_mv | 10.1006/biol.2002.0322 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72070878</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1045105602903222</els_id><sourcerecordid>72070878</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMofl89Sk_eWidp0nS9LeIXrCi4nkM-phjptmuSCvvvbdkFT-JphuF5X5iHkAsKBQWoro3v24IBsAJKxvbIMYWZyOuSwf60c5FTENUROYnxE4BSLvkhOaKMUVlydkxelh8YVrrN3pI2vvVpc5PNs2fUXcxSn81jHAJmSwzJ67AZqTDYNJ18l01RvcYheZu9hj6h7-IZOWh0G_F8N0_J-_3d8vYxX7w8PN3OF7ktJU25MWiwotRqqyvXVA0XXDYGtBCcy0o4JylqcOgaV1qDdalLiYLPjLDGzUx5Sq62vevQfw0Yk1r5aLFtdYf9EJVkIKGW9b8grSsAzmYjWGxBG_oYAzZqHfxqfFpRUJNrNblWk2s1uR4Dl7vmwazQ_eI7uSNQbwEcRXx7DCpaj51F5wPapFzv_-r-AS1sjsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18600429</pqid></control><display><type>article</type><title>Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins</title><source>ScienceDirect Freedom Collection</source><creator>Cauchy, Mike ; D'aoust, Sophie ; Dawson, Brian ; Rode, Harold ; Hefford, Mary Alice</creator><creatorcontrib>Cauchy, Mike ; D'aoust, Sophie ; Dawson, Brian ; Rode, Harold ; Hefford, Mary Alice</creatorcontrib><description>To be both safe and effective, a therapeutic product must have the correct chemical structure and be free of harmful contaminants. Structure in protein therapeutic products, however, implies not only the correct sequence of amino acids (primary structure) but also the proper folding of that amino acid chain in three-dimensional space (tertiary structure). This work is part of a general strategy to develop a battery of physico-chemical methods that could give assurances of structure (and hence function) in formulated therapeutic proteins in the absence of
in vivo data. It focuses on recombinant human growth hormone (rhGH), a well-characterized therapeutic protein, and examines the utility of thermodynamic parameters in assessing its tertiary structure. Resistance of solutions of formulated rhGH to thermal denaturation was followed using Fourier Transform Infrared Spectroscopy (FTIR) by observing decreases in total helicity and increases in intermolecular beta-sheet formation. Under conditions known to induce changes in the intra-molecular ionic and H-bonding patterns stabilizing the tertiary structure but not affecting the protein's secondary structure or global fold, we have observed upwards of a 12°C shift in the melting temperature of the protein. Furthermore, our results indicated that the
T
m of unfolding of rhGH was sensitive to much more subtle changes in the protein structure. Thus, resistance to thermal denaturation may well be a useful means to measure structure in formulations of well-characterized therapeutic proteins.
Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.</description><identifier>ISSN: 1045-1056</identifier><identifier>EISSN: 1095-8320</identifier><identifier>DOI: 10.1006/biol.2002.0322</identifier><identifier>PMID: 12217342</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Deuterium ; Drug Stability ; Hot Temperature ; Human Growth Hormone - chemistry ; Human Growth Hormone - therapeutic use ; Humans ; Hydrogen ; Hydrogen-Ion Concentration ; In Vitro Techniques ; Protein Denaturation ; Protein Structure, Tertiary ; protein structure, thermal denaturation, stability, therapeutic proteins, quality assurance, FTIR ; Recombinant Proteins - chemistry ; Recombinant Proteins - therapeutic use ; Spectroscopy, Fourier Transform Infrared ; Thermodynamics</subject><ispartof>Biologicals, 2002-09, Vol.30 (3), p.175-185</ispartof><rights>2002 The International Association for Biologicals</rights><rights>Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3</citedby><cites>FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27900,27901</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12217342$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cauchy, Mike</creatorcontrib><creatorcontrib>D'aoust, Sophie</creatorcontrib><creatorcontrib>Dawson, Brian</creatorcontrib><creatorcontrib>Rode, Harold</creatorcontrib><creatorcontrib>Hefford, Mary Alice</creatorcontrib><title>Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins</title><title>Biologicals</title><addtitle>Biologicals</addtitle><description>To be both safe and effective, a therapeutic product must have the correct chemical structure and be free of harmful contaminants. Structure in protein therapeutic products, however, implies not only the correct sequence of amino acids (primary structure) but also the proper folding of that amino acid chain in three-dimensional space (tertiary structure). This work is part of a general strategy to develop a battery of physico-chemical methods that could give assurances of structure (and hence function) in formulated therapeutic proteins in the absence of
in vivo data. It focuses on recombinant human growth hormone (rhGH), a well-characterized therapeutic protein, and examines the utility of thermodynamic parameters in assessing its tertiary structure. Resistance of solutions of formulated rhGH to thermal denaturation was followed using Fourier Transform Infrared Spectroscopy (FTIR) by observing decreases in total helicity and increases in intermolecular beta-sheet formation. Under conditions known to induce changes in the intra-molecular ionic and H-bonding patterns stabilizing the tertiary structure but not affecting the protein's secondary structure or global fold, we have observed upwards of a 12°C shift in the melting temperature of the protein. Furthermore, our results indicated that the
T
m of unfolding of rhGH was sensitive to much more subtle changes in the protein structure. Thus, resistance to thermal denaturation may well be a useful means to measure structure in formulations of well-characterized therapeutic proteins.
Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.</description><subject>Deuterium</subject><subject>Drug Stability</subject><subject>Hot Temperature</subject><subject>Human Growth Hormone - chemistry</subject><subject>Human Growth Hormone - therapeutic use</subject><subject>Humans</subject><subject>Hydrogen</subject><subject>Hydrogen-Ion Concentration</subject><subject>In Vitro Techniques</subject><subject>Protein Denaturation</subject><subject>Protein Structure, Tertiary</subject><subject>protein structure, thermal denaturation, stability, therapeutic proteins, quality assurance, FTIR</subject><subject>Recombinant Proteins - chemistry</subject><subject>Recombinant Proteins - therapeutic use</subject><subject>Spectroscopy, Fourier Transform Infrared</subject><subject>Thermodynamics</subject><issn>1045-1056</issn><issn>1095-8320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LxDAQhoMofl89Sk_eWidp0nS9LeIXrCi4nkM-phjptmuSCvvvbdkFT-JphuF5X5iHkAsKBQWoro3v24IBsAJKxvbIMYWZyOuSwf60c5FTENUROYnxE4BSLvkhOaKMUVlydkxelh8YVrrN3pI2vvVpc5PNs2fUXcxSn81jHAJmSwzJ67AZqTDYNJ18l01RvcYheZu9hj6h7-IZOWh0G_F8N0_J-_3d8vYxX7w8PN3OF7ktJU25MWiwotRqqyvXVA0XXDYGtBCcy0o4JylqcOgaV1qDdalLiYLPjLDGzUx5Sq62vevQfw0Yk1r5aLFtdYf9EJVkIKGW9b8grSsAzmYjWGxBG_oYAzZqHfxqfFpRUJNrNblWk2s1uR4Dl7vmwazQ_eI7uSNQbwEcRXx7DCpaj51F5wPapFzv_-r-AS1sjsg</recordid><startdate>20020901</startdate><enddate>20020901</enddate><creator>Cauchy, Mike</creator><creator>D'aoust, Sophie</creator><creator>Dawson, Brian</creator><creator>Rode, Harold</creator><creator>Hefford, Mary Alice</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20020901</creationdate><title>Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins</title><author>Cauchy, Mike ; D'aoust, Sophie ; Dawson, Brian ; Rode, Harold ; Hefford, Mary Alice</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Deuterium</topic><topic>Drug Stability</topic><topic>Hot Temperature</topic><topic>Human Growth Hormone - chemistry</topic><topic>Human Growth Hormone - therapeutic use</topic><topic>Humans</topic><topic>Hydrogen</topic><topic>Hydrogen-Ion Concentration</topic><topic>In Vitro Techniques</topic><topic>Protein Denaturation</topic><topic>Protein Structure, Tertiary</topic><topic>protein structure, thermal denaturation, stability, therapeutic proteins, quality assurance, FTIR</topic><topic>Recombinant Proteins - chemistry</topic><topic>Recombinant Proteins - therapeutic use</topic><topic>Spectroscopy, Fourier Transform Infrared</topic><topic>Thermodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cauchy, Mike</creatorcontrib><creatorcontrib>D'aoust, Sophie</creatorcontrib><creatorcontrib>Dawson, Brian</creatorcontrib><creatorcontrib>Rode, Harold</creatorcontrib><creatorcontrib>Hefford, Mary Alice</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biologicals</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cauchy, Mike</au><au>D'aoust, Sophie</au><au>Dawson, Brian</au><au>Rode, Harold</au><au>Hefford, Mary Alice</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins</atitle><jtitle>Biologicals</jtitle><addtitle>Biologicals</addtitle><date>2002-09-01</date><risdate>2002</risdate><volume>30</volume><issue>3</issue><spage>175</spage><epage>185</epage><pages>175-185</pages><issn>1045-1056</issn><eissn>1095-8320</eissn><abstract>To be both safe and effective, a therapeutic product must have the correct chemical structure and be free of harmful contaminants. Structure in protein therapeutic products, however, implies not only the correct sequence of amino acids (primary structure) but also the proper folding of that amino acid chain in three-dimensional space (tertiary structure). This work is part of a general strategy to develop a battery of physico-chemical methods that could give assurances of structure (and hence function) in formulated therapeutic proteins in the absence of
in vivo data. It focuses on recombinant human growth hormone (rhGH), a well-characterized therapeutic protein, and examines the utility of thermodynamic parameters in assessing its tertiary structure. Resistance of solutions of formulated rhGH to thermal denaturation was followed using Fourier Transform Infrared Spectroscopy (FTIR) by observing decreases in total helicity and increases in intermolecular beta-sheet formation. Under conditions known to induce changes in the intra-molecular ionic and H-bonding patterns stabilizing the tertiary structure but not affecting the protein's secondary structure or global fold, we have observed upwards of a 12°C shift in the melting temperature of the protein. Furthermore, our results indicated that the
T
m of unfolding of rhGH was sensitive to much more subtle changes in the protein structure. Thus, resistance to thermal denaturation may well be a useful means to measure structure in formulations of well-characterized therapeutic proteins.
Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>12217342</pmid><doi>10.1006/biol.2002.0322</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1045-1056 |
ispartof | Biologicals, 2002-09, Vol.30 (3), p.175-185 |
issn | 1045-1056 1095-8320 |
language | eng |
recordid | cdi_proquest_miscellaneous_72070878 |
source | ScienceDirect Freedom Collection |
subjects | Deuterium Drug Stability Hot Temperature Human Growth Hormone - chemistry Human Growth Hormone - therapeutic use Humans Hydrogen Hydrogen-Ion Concentration In Vitro Techniques Protein Denaturation Protein Structure, Tertiary protein structure, thermal denaturation, stability, therapeutic proteins, quality assurance, FTIR Recombinant Proteins - chemistry Recombinant Proteins - therapeutic use Spectroscopy, Fourier Transform Infrared Thermodynamics |
title | Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T12%3A18%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thermal%20Stability:%20A%20Means%20to%20Assure%20Tertiary%20Structure%20in%20Therapeutic%20Proteins&rft.jtitle=Biologicals&rft.au=Cauchy,%20Mike&rft.date=2002-09-01&rft.volume=30&rft.issue=3&rft.spage=175&rft.epage=185&rft.pages=175-185&rft.issn=1045-1056&rft.eissn=1095-8320&rft_id=info:doi/10.1006/biol.2002.0322&rft_dat=%3Cproquest_cross%3E72070878%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c371t-bbebe611caca6df6f4547fb0a5544765dd71ea0dedfd3cbe83a37e549b5cbd9b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18600429&rft_id=info:pmid/12217342&rfr_iscdi=true |